IRIS
VISCIDO, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.081
EU - Europa 3.008
AS - Asia 2.198
SA - Sud America 268
AF - Africa 21
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.057
IE - Irlanda 974
SG - Singapore 750
CN - Cina 627
TR - Turchia 382
RU - Federazione Russa 378
HK - Hong Kong 368
DE - Germania 363
IT - Italia 330
BR - Brasile 238
SE - Svezia 238
UA - Ucraina 216
GB - Regno Unito 172
FI - Finlandia 127
FR - Francia 90
CZ - Repubblica Ceca 38
BE - Belgio 30
IN - India 22
NL - Olanda 18
AR - Argentina 16
CA - Canada 16
VN - Vietnam 13
ZA - Sudafrica 9
IQ - Iraq 8
AT - Austria 7
JP - Giappone 7
LT - Lituania 6
EC - Ecuador 5
VE - Venezuela 5
AU - Australia 4
ES - Italia 4
EU - Europa 4
MA - Marocco 4
IL - Israele 3
JO - Giordania 3
RO - Romania 3
TN - Tunisia 3
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
GE - Georgia 2
JM - Giamaica 2
KE - Kenya 2
LU - Lussemburgo 2
MX - Messico 2
NZ - Nuova Zelanda 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BM - Bermuda 1
BT - Bhutan 1
EE - Estonia 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TG - Togo 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 10.586
Salva come PNG Salva come JPEG
Città #
Chandler 979
Dublin 964
Jacksonville 941
Hong Kong 367
Ashburn 344
Santa Clara 343
Singapore 343
Boardman 318
Izmir 197
Nanjing 159
San Mateo 151
Lawrence 149
Princeton 149
Wilmington 142
New York 118
Ann Arbor 114
Moscow 94
Beijing 91
Dearborn 76
L'aquila 62
Milan 52
Bremen 50
Woodbridge 42
Helsinki 38
Brno 37
Des Moines 37
Los Angeles 37
Shenyang 37
Nanchang 36
Seattle 34
Verona 32
Kunming 31
Tianjin 31
Brussels 30
Berlin 28
Munich 28
Shanghai 27
Jinan 25
Norwalk 24
Rome 24
São Paulo 24
The Dalles 23
Dallas 18
Jiaxing 18
Zhengzhou 18
Council Bluffs 17
Hebei 16
Frankfurt am Main 14
London 14
L’Aquila 14
Falkenstein 13
Mountain View 13
Changsha 12
Dong Ket 12
Fairfield 11
Rio de Janeiro 11
Hefei 10
Ningbo 10
Pescara 10
Fremont 9
Hangzhou 9
Mumbai 9
Amsterdam 8
Changchun 8
Guangzhou 8
Phoenix 8
Toronto 8
Brasília 7
Auburn Hills 6
Düsseldorf 6
Pune 6
Reggio Nell'emilia 6
Tappahannock 6
Cedar Knolls 5
Edinburgh 5
Falls Church 5
Padova 5
Vienna 5
Belo Horizonte 4
Bologna 4
Borgosatollo 4
Campinas 4
Florence 4
Genoa 4
Lappeenranta 4
Portsmouth 4
San Francisco 4
Stockholm 4
Amman 3
Baghdad 3
Bari 3
Betim 3
Cape Town 3
Chaozhou 3
Haikou 3
Huskvarna 3
Johannesburg 3
Langfang 3
Lanzhou 3
Madrid 3
Totale 7.264
Salva come PNG Salva come JPEG
Nome #
Efficacia di un nuovo preparato di olio di pesce sulla recidiva del Morbo di Crohn. Giornale di Gastroenterologia 1996;1:158-162 310
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 139
Association between colonic diverticula and colorectal polyps and cancer 125
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 122
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 121
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 120
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 112
Association between colorectal polyps and colonic diverticulosis 110
Histological healing in ulcerative colitis with mesalazine and its prognostic role 103
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. 97
Colite acuta dopo colonscopia. Giornale di Gastroenterologia 1997; 2: 88-93 96
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. 94
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. 93
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nation-wide study. 92
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 91
In favour of prophylactic treatment for post-operative recurrence in Crohn's disease. 90
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 86
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 85
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 84
Current management of severe ulcerative colitis. 84
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) 83
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 82
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. 82
Acute colitis following endoscopy: an outbreak of three cases 82
Il 5-ASA (ASACOL) previene le recidive post-operatorie del morbo di crohn (MC): risultati dello studio GISC a tre anni di follow-up. 82
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 82
Nanotechnology in the treatment of inflammatory bowel diseases. 81
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 80
Safe use of infliximab for the treatment of fistulizing Crohn’s disease during pregnancy within 3 months of conception. 80
NK activity and antibody-dependent cellular citotoxicity (ADCC) in inflammatory bowel disease(IBD) 79
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 79
MRI in Crohn’s disease: assessment of treatment response or relapse 79
Prognostic factors for post-operative recurrence of Crohn's disease 78
Mucosal healing: Mayo 0 vs 1 after 3 years. 78
Acute colitis following colonoscopy 77
GI distension in severe ulcerative colitis 77
A mathematical model to study natural history of crohn’s disease. 76
Small intestine contrast ultrasonography: An alternative to radiology in the assessment of small bowel disease 76
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 75
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 74
Value of T2-weighted fat suppressed and non suppressed sequences after oral administration of a superparamagnetic contrast agent in the assessmento of Crohn's disease activity 74
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 74
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 74
A new technique of magnetic resonance imaging (MRI) in the management of patients with Crohn's disease. 73
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 73
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 73
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 73
Recidive stenosanti ricorrenti nel morbo di Crohn. Giornale di Gastroenterologia, 1999, 4: 150-155 73
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A pragmatic double blind randomised controlled trial . Aliment Pharmacol Ther 2003;17:517-523 73
Are volatile organic compounds accurate markers in the assessment of colorectal cancer and inflammatory bowel diseases? A review 73
An unusual treatment for a colonic polyp. 72
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. 72
Quinidine-induced colitis. Report of three cases. 72
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A double blind randomised clinical trial. AGISC study. 72
Recidiva postoperatoria del morbo di Crohn: un modello matematico per lo studio dell'evoluzione delle lesioni. 71
L’intestino nei pazienti critici. La barriera mucosa intestinale e le sue alterazioni (prima parte). Giornale di Gastroenterologia 1998; 3: 70-103 71
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 71
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 70
MRI EVALUATION OF CROHN DISEASE OF THE SMALL AND LARGE BOWEL USING NEGATIVE SUPERPARAMAGNETIC CONTRAST AGENT 70
CDAI is inadequate for diagnosis of post-operative recurrence of Crohn’s Disease 70
Mucosal concentration of 5-ASA in the distal colon. Comparison between oral and plus topical treatment. 70
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 70
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 69
Colonic mucosal concentration of 5-ASA in ulcerative colitis. 69
Linfociti circolanti gamma-delta in corso di malattie infiammatorie intestinali. 69
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 69
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 69
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 68
Gastrointestinal distension in severe ulcerative colitis 68
Gastrointestinal distension in severe ulcerative colitis (UC). 68
Multiple organ dysfunction complicating severe ulcerative colitis. 68
Duodenal lymphocytosis in functional dyspepsia 68
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. 67
Early versus late surgery for ileo-caecal Crohn's disease. 67
Post-operative recurrence of Crohn’s Disease: a study for the development of lesions in treated and untreated patients. 67
Unmet medical needs in the management of ulcerative colitis: Results of an Italian delphi consensus 67
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 67
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis 67
Multiple organ dysfunction syndrome (MODS) complicating severe ulcerative coliyis (UC) 66
The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics 66
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 66
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? 66
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies 66
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 65
Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literature 65
Is mesalazine treatment effective in the prevention of diverticulitis? A review 65
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 65
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease? 65
Surgery at diagnosis of Crohn’s disease reduces the need for steroids and immunomodulators 64
Detection of post-operative recurrence in Crohns disease (CD). 64
Detection of post-operative recurrence in Crohns disease (CD). Proceedings of 5th Congress of the European Council for Coloproctology (ECCP), Barcellonas, Spain, June 14-17, 1995. Edited by J. Martì Raguè and J. de Oca Burguete, Barcelona (Spain), Monduzzi Editore, 1995: p.63-66 64
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 64
Diarrea Cronica In: Disturbi cronici intestinali, E.Corazziari Ed., Milano, Messaggi, 2003:127-135 63
Risk of colonoscopic post-polypectomy bleeding in patients on single antiplatelet therapy: systematic review with meta-analysis 63
Postoperative recurrence in Crohn's disease. 62
"Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. 62
Il CDAI è inadeguato per la diagnosi della recidiva post-operatoria del morbo di Crohn. 61
Duodenal Intraepithelial CD8+ Lymphocytosis in Patients with Functional Dyspepsia. 61
Mesalazine vanishing time from rectal mucosa following its topical administration. 61
Two mesalazine regimens in the prevention of postoperative recurrence (POR) of Crohn's disease: A double blind randomised controlled trial by GISC with a meta-analysis of other studies. 61
Totale 7.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020138 0 0 0 0 0 0 0 0 0 0 14 124
2020/20211.113 36 134 3 168 146 25 150 17 137 28 232 37
2021/2022799 34 60 94 39 32 27 12 58 43 32 68 300
2022/20232.841 216 159 44 293 257 301 0 204 1.233 16 84 34
2023/2024990 98 28 29 91 47 167 30 285 4 39 51 121
2024/20252.657 69 50 288 98 298 317 382 265 692 190 8 0
Totale 10.826